Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis

Area of Science:

• Nanomedicine
• Cardiovascular Diseases
• Biomaterials

Background:

• Cardiovascular diseases (CVDs) are a leading cause of global mortality, presenting significant challenges in treatment and diagnosis.
• Nanomedicine offers innovative solutions for CVDs through advanced treatments, imaging agents, and diagnostics.
• Current nanomedicine applications in CVDs include enhancing cardiac biomaterials, developing vasculature therapeutics, and improving diagnostic devices.

Purpose of the Study:

• To review recent studies on organic nanoparticles for cardiovascular applications.
• To highlight the potential of nanomedicine in addressing limitations in CVD diagnosis and therapy.

Main Methods:

• Review of the latest research on organic nanoparticles in cardiovascular illness.
• Focus on drug-conjugated polymers, lipid nanoparticles, and micelles.
• Analysis of nanomedicine's role in cardiac biomaterials, vasculature applications, and ex vivo diagnostics.

Main Results:

• Organic nanoparticles demonstrate significant potential in cardiovascular applications.
• Biocompatibility and drug integration capabilities are key advantages.
• Nanoparticle-based approaches can enhance cardiac function and vascular treatments.

Conclusions:

• Organic nanoparticles represent a promising therapeutic strategy for cardiovascular diseases.
• Their properties offer improved biocompatibility and drug delivery for CVD management.
• Further research into organic nanoparticles could revolutionize cardiovascular medicine.